About (Vision/aims of the ProCAncer-I project)

The ProCAncer-I project brings together 20 partners, with recognized expertise in their field, such as clinical reference centers for prostate cancer, experts in Artificial Intelligence and machine learning, and innovative SMEs. The goal is to design, develop and operate an Artificial Intelligence Platform in which high-quality PCa imaging data, as well as relevant clinical data, are stored. The data are used to train advanced AI computational models in order to support clinicians for a more accurate prognosis and optimal management of prostate cancer.

Learn more about the project

Exploring the Intersection of mpMRI and Digital Histopathology in Prostate Cancer Management: Opportunities and Challenges

ProCAncer-I at the ECR 2024 in Vienna

Europa Uomo webinar with the ProCAncer-I Project

Our 6th issue of the ProCAncer-I newsletter has been published!

The ProCAncer-I at the IEEE Engineering in Medicine & Biology Society (EMBS) in Malta

The ProCAncer-I Consortium is organising a mini symposium under the scope Data Engineering in Cancer, chaired by prof. Dimitris Fotiadis and are inviting every interested stakeholder to participate. The mini symposium will take place during the IEEE EMBS International Conference on Data Science and Engineering in Healthcare, Medicine & Biology, in Malta (Hilton Malta Hotel) on December 7, 2023 – December 9, 2023, on the second day.

ProCAncer-I at the “Al and Cancer: Unleashing Opportunities, Overcoming Challenges” workshop

240 professionals from more than 20 countries registered for the workshop event ’Al and Cancer: Unleashing Opportunities, Overcoming Challenges’, coorganized by INCISIVE, EUCAIM, and the AI4HI cluster, with the local support of Medtronic and TIC Salut Social Foundation, the 7th of November in Madrid, Spain.

Prof Tsiknakis: Launch of the federal European infrastructure for cancer imaging

The EUCAIM (European Federation for Cancer Images) project is the cornerstone of the European Cancer Imaging Initiative, launched by the European Commission, within the framework of the European Beating Cancer Plan, emphasized Prof. Manolis Tsiknakis, as Coordinator of the ProCAncer-I project and Affiliated Professor at the Computational Biomedicine Laboratory (CBML), speaking at the Health IT conference.

EUCAIM unveils first release of groundbreaking platform to fuel collaborative innovation and data sharing across Europe

EUCAIM unveils first release of groundbreaking platform to fuel collaborative innovation and data sharing across Europe

The EHDS Proposal & the ProCAncer-I Project: Diverging Visions of the Data-Value-Chain?

Taking an innovative approach to applying artificial intelligence (AI) to medical imaging, Quibim is designing predictive panels to enable healthcare providers to improve patient outcomes.

ProCAncer-I at the IEEE EMBC 2023 in Sydney

EMBC 2023 is the 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. The conference was held in Sydney, Australia from 24th to 27th July 2023. 

Challenges of the ProCAncer-I project

The goal of the project is to address critical clinical questions related to the management of prostate cancer. How? by developing an Artificial Intelligence platform.

Over 18,000 patient cases

The platform hosts the largest collection of prostate cancer data worldwide: Multiparametric (MP) MRI images, derived from anonymized data. In total, it hosts more than 18,396 cases from 9,618 patients and around 5.8 million images of prostate cancer.

Training AI models

The computational models based on machine learning and deep learning techniques, once confirmed, regarding the correctness and accuracy of their operation (technical and clinical validation), will be accessible through the ProCAncer-I platform for use by clinicians to accelerate the progress in cancer treatment. Thus, thousands of men will deal with prostate cancer in a more personalized way while enjoying a better quality of life.

Accessible to everybody

ProCAncer-I aims to develop a sustainable platform for all, connecting prostate cancer practitioners, radiologists, clinical researchers and AI developers, with patients and relevant industry stakeholders.



Useful resources for patients

Europa Uomo

Europa Uomo (Italian for Europe man) is a European advocacy movement representing 27 prostate patients’ groups in countries across Europe.



European Cancer Patient Coalition

With over 450 members, ECPC is the largest European non-profit cancer patients’ association. Covering all 27 European Union Member States, and many other European and non-European countries, represents those affected by all types of cancers, from the rarest to the most common.


European Association of Urology

The EAU represents the leading authority within Europe on urological practice, research, and education. Over 19,000 medical professionals have joined its ranks and contributed to our mission: To raise the level of urological care throughout Europe and beyond.